• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GTG 0.00% 12.0¢

GENETIC TECHNOLOGIES LIMITED - News & Media

Genetic Technologies Limited is an Australia-based diversified molecular diagnostics... Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company operates through three segments: EasyDNA, AffinityDNA, and GeneType / Corporate. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses. GeneType / Corporate segment relates to geneType branded test sales and expenses, including corporate charges. The GeneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and morMore

(20min delay)
Last
12.0¢
Change
0.000(0.00%)
Mkt cap ! $15.86M
Open High Low Value Volume
12.0¢ 12.0¢ 11.0¢ $4.415K 36.83K

Buyers (Bids)

No. Vol. Price($)
1 17530 11.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.0¢ 4879 2
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.